D. Gill

发表

A genome-wide association study for nonalcoholic fatty liver disease identifies novel genetic loci and trait-relevant candidate genes in the Million Veteran Program.

Christopher D. Brown, Liu, Sun, 2021, medRxiv.

Cardiometabolic traits, sepsis and severe covid-19 with respiratory failure: a Mendelian randomization investigation

V. Zuber, C. Willer, K. Hveem, 2020, medRxiv.

Sparse dimensionality reduction approaches in Mendelian randomisation with highly correlated exposures

V. Zuber, J. Bowden, D. Gill, 2022, medRxiv.

Genetic risk and incident venous thromboembolism in middle‐aged and older adults following COVID‐19 vaccination

A. Prats-Uribe, D. Gill, D. Prieto-Alhambra, 2022, Journal of Thrombosis and Haemostasis.

Genome-wide association study of skin and soft tissue infection susceptibility

Laurent F. Thomas, C. Willer, K. Hveem, 2020, medRxiv.

Genetically proxied inhibition of interleukin-6 signaling: opposing associations with susceptibility to COVID-19 and pneumonia

S. Larsson, S. Burgess, D. Gill, 2020, medRxiv.

Genetically proxied impaired GIPR signaling and risk of 6 cancers

V. Moreno, G. Davey Smith, M. Gunter, 2022, medRxiv.

An empirical investigation into the impact of winner’s curse on estimates from Mendelian randomization

A. Butterworth, S. Burgess, T. Jiang, 2022, medRxiv.

The consequences of adjustment, correction and selection in genome-wide association studies used for two-sample Mendelian randomization

I. Tzoulaki, N. Davies, D. Gill, 2020, medRxiv.

The UK BiLEVE and Mendelian randomisation: using multivariable instrumental variables to address “damned if you, damned if you don’t” adjustment problems

M. Munafo, H. Sallis, D. Gill, 2022, BMC Research Notes.

Re-evaluating the robustness of Mendelian randomisation to measurement error

K. Tilling, V. Karhunen, J. Yarmolinsky, 2022, medRxiv.

TwoStepCisMR: A novel method and R package for attenuating bias in cis-MR

B. Woolf, D. Gill, 2022, medRxiv.

Genetically-proxied anti-diabetic drug target perturbation and risk of cancer: a Mendelian randomization analysis

E. E. Vincent, S. Lewis, B. Voight, 2022, medRxiv.

MVMRmode: Introducing an R package for plurality valid estimators for multivariable Mendelian randomisation

S. Burgess, B. Woolf, D. Gill, 2023, medRxiv.

Genetically proxied PCSK9 inhibition provides indication of lower prostate cancer risk: a Mendelian randomization study

Tom R. Gaunt, G. Davey Smith, D. Gill, 2022, medRxiv.

Avoiding bias in Mendelian randomization when stratifying on a collider

N. Malats, S. Burgess, D. Gill, 2021, medRxiv.

Circulating concentrations of micro-nutrients and risk of breast cancer: A Mendelian randomization study

E. Riboli, S. Lewis, I. Tzoulaki, 2019, bioRxiv.

The association of genetically proxied sildenafil with fertility, sexual activity, and wellbeing: a Mendelian randomisation study

J. Yarmolinsky, B. Woolf, D. Gill, 2023, medRxiv.

Assessing the Causal Effects of Environmental Tobacco Smoke Exposure: A meta-analytic Mendelian randomisation study

M. Munafo, H. Sallis, B. Woolf, 2023, medRxiv.

Venous Thromboembolism in Ambulatory Covid-19 patients: Clinical and Genetic Determinants

A. Prats-Uribe, D. Gill, D. Prieto-Alhambra, 2022, medRxiv.

Comparison of caffeine consumption behavior with plasma caffeine levels as exposures in drug-target Mendelian randomization and implications for interpreting effects on obesity

S. Larsson, S. Burgess, B. Woolf, 2023, medRxiv.

Pathways mediating the effect of education on pregnancy outcomes: A Mendelian randomization study

T. Rogne, Z. Liew, D. Gill, 2023, medRxiv.

Robust use of phenotypic heterogeneity at drug target genes for mechanistic insights: application of cis-multivariable Mendelian randomization to GLP1R gene region

D. Shungin, S. Burgess, D. Gill, 2023, medRxiv.